Xisco Quesada, a 28-year-old from Mallorca and father of two, has died after suffering from pancreatic cancer with metastasis. His family announced his death on Wednesday in a post on his Instagram account, @xiscoquesada9, the profile from which he had shared information about his medical condition in recent months. In the statement, the family explained: "It is with deep sadness that we announce the passing of Xisco," and recalled that "his life changed completely when he was diagnosed with pancreatic cancer with metastasis." They also noted that, from that moment on, he decided "to share his daily life unfiltered, showing the process, his fears, and also a strength that left us speechless."

With the slogan "Together we are a 10," some 5,000 people participated this Sunday in the 10th edition of the charity race "Mallorca en Marcha contra el Cáncer," organized by the Spanish Association Against Cancer in the Balearic Islands, the organization reported.

The Spanish Association Against Cancer (AECC) in the Balearic Islands will hold the tenth edition of the Mallorca en Marcha contra el Cáncer charity race on Sunday, October 26th, an already established event in the island's sporting and charity calendar.

A study by the Balearic Islands Health Research Institute (IDISBA) revealed hidden mutations in little-explored areas of human DNA, known as 'dark DNA,' that could drive the progression of aggressive brain tumors. A discovery that opens the door to better diagnosis of the disease. The international team led by Dr. Diego Marzese has discovered genetic changes in little-explored areas of human DNA that could help explain why glioblastoma, the most aggressive brain tumor, is so difficult to treat, the Regional Ministry of Health explained in a statement.

The Ministry of Health has launched the second phase of the pilot program for early detection of cervical cancer among more than 400 women at the Campos Health Center. It is a quick and easy test that detects the presence of high-risk HPV types that could cause cervical cancer. If the results are negative, this test is repeated every five years. Uterine cancer is the result of a previous infection with the Human Papillomavirus (HPV), which is sexually transmitted. Even so, the vast majority of infections are temporary and do not cause any problems. Their immune systems are less able to fight HPV. The disease can take a decade to develop after infection; therefore, most diagnoses occur among women between the ages of 35 and 50.

The Health Living Lab of the Son Espases University Hospital and the Adema University School have launched a pioneering technological project at the international level which, according to its promoters, marks a milestone in medical-surgical training: it is a haptic (tactile) simulation system)applied to virtual training to treat colorectal cancer so that in the future it can be extrapolated to real interventions in different areas of surgery.

A study by the Hospital del Mar Research Institute, with the participation of the Oncology and Pathology Departments, researchers from the Spanish Breast Cancer Research Group (GEICAM) and led by the Mallorcan researchers Toni Celià-Terrassa and Catalina Rozalén has found a new way to stop the breast cancer metastasis, at the time of micrometastasis. That is, when the first cells reach other organs. The work has identified the role of the TIM-3 protein in the most aggressive cells that initiate metastasis. The TIM-3 protein allows tumor cells to suppress the immune system when they reach distant organs, thus ensuring their survival at a critical moment. This fact makes it a moment of therapeutic opportunity and turns TIM-3 into a "unique and specific" therapeutic target for this "precise moment" of the disease.